台股 » 個股 » 逸達 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

逸達

(6576)
  • 股價
    77.5
  • 漲跌
    ▲0.5
  • 漲幅
    +0.65%
  • 成交量
    191
  • 產業
    上櫃 生技醫療類股
  • 118人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
逸達 (6576)籌碼相關-富邦-新莊 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-新莊 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/2200.00277.5077.50-2198-1.01%
2025/01/20076.6000.0076.3001950.00%
2025/01/15076.3000.0076.3001940.00%
2025/01/140.176.3000.0076.300.11940.05%
2024/12/11273.8000.0073.8021581.26%
2024/12/10273.9000.0073.4021561.28%
2024/12/0900.00075.9075.4001490.00%
2024/11/20176.9000.0076.8011010.99%
2024/10/29278.5500.0077.8021231.62%
2024/10/24279.5000.0078.8021351.48%
2024/10/23177.5000.0077.9011360.73%
2024/10/22276.8000.0076.8021371.46%
2024/10/21178.0000.0077.8011390.71%
2024/10/0100.00082.6082.7001730.00%
2024/09/0600.00079.7079.8002630.00%
2024/08/1900.00280.1080.00-2294-0.68%
2024/08/150.177.5000.0078.000.12940.03%
2024/08/140.178.3900.0078.400.12950.03%
2024/08/1200.00379.7079.60-3297-1.01%
2024/08/08176.6000.0076.4013000.33%
2024/08/05373.6700.0072.5032991.00%
2024/07/30279.9000.0080.4022930.68%
2024/07/16183.1000.0083.2012770.36%
2024/07/15183.0000.0083.4012840.35%
2024/07/121.283.2400.0083.401.22820.41%
2024/07/11783.7600.0083.4072802.50%
2024/07/08285.1000.0084.2022800.71%
2024/07/03185.0000.0084.1012730.37%
2024/07/02284.50083.6084.3022740.73%
2024/07/01383.4700.0084.5032721.10%
2024/06/28183.7000.0083.5012700.37%
2024/06/26183.8000.0084.3012660.38%
2024/06/25282.2000.0083.5022600.77%
2024/06/24190.4000.0089.2012380.42%
2024/06/0700.00199.4099.60-1220-0.45%
2024/05/15194.0000.0093.6013210.31%
2024/05/09194.0000.0093.8013220.31%
2024/05/07194.6000.0094.4013190.31%
2024/05/02295.9000.0096.0023190.63%
2024/04/29195.6000.0095.5013190.31%
2024/04/2600.00094.7095.0003180.00%
2024/04/24294.8500.0095.1023210.62%
2024/04/2200.00094.8094.0003310.00%
2024/04/1900.003995.4593.60-39339-11.50%
2024/04/17196.8000.0097.0013310.30%
2024/04/1600.00296.0096.80-2334-0.60%
2024/04/11099.4000.0099.4003310.00%
2024/04/0900.001798.6999.10-17332-5.11%
2024/04/0800.00299.0099.60-2329-0.61%
2024/03/2200.00594.9495.50-5373-1.34%
2024/03/21294.6000.0095.0023780.53%
2024/03/15595.5800.0094.5053731.34%
2024/03/14495.00394.8795.1013710.27%
2024/03/12195.6000.0096.1013690.27%
2024/03/08095.4000.0095.7003720.00%
2024/03/0400.001102.00102.00-1349-0.29%
2024/02/261103.0000.00104.5013390.29%
2024/02/2200.001103.00102.00-1352-0.28%
2024/02/2000.001106.00106.00-1340-0.29%
2024/02/190106.002106.50107.00-2322-0.62%
2024/02/1600.00896.9497.80-8288-2.78%
2024/02/0100.00294.0094.30-2287-0.70%
逸達前列腺癌新劑型新藥 確立美國藥證審查完成目標日Anue鉅亨-15天前
逸達營收/去年4.2億、年增115% 今年拚歐、美、中新藥藥證UDN聯合新聞網-21天前
逸達進軍歐盟 首批前列腺癌新劑型新藥正式出貨Anue鉅亨-2024/12/18
逸達 相關文章
逸達 相關影音